Abstract: Provided are substituted 8-methylquinazolin-4(3H)-one compounds useful as PARP inhibitors for the treatment of cancer and asthma, as well as pharmaceutical compositions comprising them and methods for their synthesis.
Abstract: Provided are near-infrared nerve-sparing fluorescent compounds, compositions comprising them, and methods of their use in medical procedures.
Type:
Grant
Filed:
September 11, 2019
Date of Patent:
July 9, 2024
Assignee:
Oregon Health & Science University
Inventors:
Summer L. Gibbs, Lei G. Wang, Connor W. Barth
Abstract: Provided herein are compounds, pharmaceutical formulations, and methods for treatment of cancer, particularly including chronic myeloid leukemias, and neurodegenerative disorders in a subject.
Type:
Application
Filed:
April 19, 2022
Publication date:
June 20, 2024
Applicants:
Oregon Health & Science University, The Board of Trustees of the Leland Stanford Junior University
Inventors:
Sanjay Malhotra, Mallesh Pandrala, Dhanir Tailor, Arne A.N. Bruyneel, Mark Mercola, Anna P. Hnatiuk Hnatiuk
Abstract: Described herein are new synthetic routes for production of Endochin-Like Quinolone (ELQ) compounds. Synthetic routes to 3-substituted 4(1H)-quinolones are presented that are amenable to industrial scale preparation. One herein presented approach is relatively short, does not require palladium, and involves no chromatographic separation. A second herein presented approach is similarly relatively short, does not require palladium, involves no chromatographic separation, and also avoids high vacuum distillation. Additionally, both approaches require no protecting group chemistry because the insoluble 4(1H)-quinolone is not formed until the final reaction step.
Type:
Application
Filed:
March 17, 2022
Publication date:
June 6, 2024
Applicants:
Oregon Health & Science University, The United States Government as Represented by the Department of Veterans Affairs
Inventors:
Michael K. Riscoe, Aaron Nilsen, Haihong Jin, Sovitj Pou, Rolf W. Winter, Rozalia Ana Dodean, Katherine M. Liebman
Abstract: The present disclosure relates to molecular barcodes comprising a set of one or more identimers. Methods of using the molecular barcodes, such as to classify a material, are disclosed. Methods of making the molecular barcodes and systems for using the molecular barcodes are disclosed herein.
Abstract: This disclosure describes systems, devices, and techniques for training neural networks to identify avascular and signal reduction areas of Optical Coherence Tomography Angiography (OCTA) images and for using trained neural networks. By identifying signal reduction areas in OCTA images, the avascular areas can be detected with high accuracy, even when the OCTA images include artifacts and other types of noise. Accordingly, various implementations described herein can accurately identify avascular areas from real-world clinical OCTA images. In various implementations, a method can include identifying images of retinas. The images may include thickness images, reflectance intensity maps, and OCTA images of the retinas. Avascular maps corresponding to the OCTA images can be identified. A neural network can be trained based on the images and the avascular maps.
Abstract: Recombinant polypeptides comprising a modified DR?1 domain are provided. In some embodiments, the polypeptides include the modified DR?1 domain, an antigenic peptide, and optionally a linker sequence. Pharmaceutical compositions comprising the recombinant polypeptides, methods of treating inflammatory disease using said recombinant polypeptides or pharmaceutical compositions, and expression constructs comprising nucleic acids that encode the recombinant polypeptides are also provided.
Type:
Grant
Filed:
October 4, 2019
Date of Patent:
April 2, 2024
Assignees:
Oregon Health & Science University, The United States Government as represented by the Department of Veterans Affairs
Inventors:
Roberto Meza-Romero, Arthur A. Vandenbark, Halina Offner
Abstract: Disclosed are methods and systems correcting bulk-motion artifacts in phase-based functional OCT images. The disclosed methods and systems are based on the use of the standard deviation of the phase shift signal present in phase-based OCT imaging. When applied with functional OCT techniques such as OCT angiography, Doppler OCT, and OCT elastography, the disclosed methods provide improved image quality and decreased computational cost compared to other methods of bulk motion compensation.
Abstract: Disclosed herein are methods and systems for optical coherence tomography (OCT) angiography (OCTA). An interleaved scanning pattern is described herein for both raster and bidirectional scanning methods. The interleaved scanning pattern provides B-scans with different scanning intervals. OCTA images based on the B-scans may be combined to obtain a high dynamic range (HDR) OCTA image. Other embodiments may be described and claimed.
Abstract: The present disclosure is concerned with 2-pyrimidone compounds that are capable of inhibiting a viral infection and methods of treating alphavirus viral infections such as, for example, chikungunya, Eastern equine encephalitis (EEEV), Western equine encephalitis (WEEV), and Venezuelan equine encephalitis using these compounds. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
Type:
Grant
Filed:
December 13, 2022
Date of Patent:
March 19, 2024
Assignees:
Southern Research Institute, Oregon Health and Science University
Inventors:
Ashish Kumar Pathak, Corinne E. Augelli-Szafran, Atefeh Garzan, Daniel Steblow, Nicole Haese
Abstract: Disclosed are immunogenic constructs including: a nanoparticle; a cationic polymer electrostatically bound to an exterior surface of the nanoparticle and a stabilizer bound to the cationic polymer or the exterior surface of the nanoparticle; and an antigen or antigen producing agent. Optionally, the constructs may include adjuvant and/or one or more functional oligonucleotide(s) (e.g., siRNA or pDNA). Also disclosed are methods of using the provided immunogenic constructs for co-delivering an adjuvant, antigen, and optionally siRNA to a cell, inducing immune response in a subject, and treating or preventing an infectious disease in a subject.
Type:
Application
Filed:
August 18, 2023
Publication date:
March 7, 2024
Applicants:
Oregon Health & Science University, PDX Pharmaceuticals, Inc.
Abstract: Disclosed are methods and systems for signal attenuation-compensated projection-resolved (sacPR) optical coherence tomography angiography (OCTA). The sacPR OCTA may be free of segmentation and vascular contrast enhancement. In some embodiments, projection artifacts may be suppressed with signal compensation including flow and large vessel shadow compensation for projection removal and wavelet-based compensation for noise suppression.
Abstract: The present technology relates to compounds of any one of Formula I, II, IIa, III, IV, and/or V as described herein and their tautomers and/or pharmaceutically acceptable salts, compositions, and methods of uses thereof.
Type:
Application
Filed:
March 16, 2023
Publication date:
February 29, 2024
Applicants:
UNIVERSITY OF KANSAS, Oregon Health & Science University
Inventors:
Sudeshna ROY, Paolo BERNARDI, Michael FORTE, Frank SCHOENEN, Justina SILEIKYTE
Abstract: Disclosed is a handheld laser probe for laser thermal conjunctivoplasty, the handheld laser comprising: a forceps; and a line focused laser light source coupled to the forceps, wherein the forceps are configured to grasp a conjunctival fold and hold the fold in a light beam of the line focused laser, and wherein the line focused laser beam is configured to uniformly heat the conjunctival fold held in the forceps. Disclosed are systems for laser thermal conjunctivoplasty including the handheld laser. Disclosed are methods of conjunctivoplasty using the handheld laser probe.
Type:
Grant
Filed:
February 27, 2018
Date of Patent:
February 13, 2024
Assignees:
OREGON HEALTH & SCIENCE UNIVERSITY, BAYLOR COLLEGE OF MEDICINE
Inventors:
David Huang, Gangjun Liu, Jianlong Yang, Stephen Pflugfelder
Abstract: Methods and systems for identifying CNV membranes and vasculature in images obtained using noninvasive imaging techniques are described. An example method includes generating, by a first model based on at least one image of a retina of a subject, a membrane mask indicating a location of a CNV membrane in the retina. The method further includes generating, by a second model based on the membrane mask and the at least one image, a vasculature mask of the retina of the subject, the vasculature mask indicating CNV vascularization in the retina.
Abstract: Embodiments include a delivery device for an auxetic device. The delivery device is comprised of an outer constraining device and a longitudinal controlling device disposed concentrically within the outer constraining device and offset to form a chamber for receiving the auxetic device. A mechanism coupled to the outer constraining device and the longitudinal controlling device allows the chamber size to adjust longitudinally as the auxetic device is deployed. Other embodiments may be described and/or claimed.
Type:
Application
Filed:
October 13, 2021
Publication date:
January 18, 2024
Applicant:
OREGON HEALTH & SCIENCE UNIVERSITY
Inventors:
Ramsey Al-Hakim, Khashayar Farsad, John A. Kaufman
Abstract: Provided herein are novel azopodophyllotoxin analog compounds, pharmaceutical compositions comprising them, and their use as inhibitors of Y box protein 1 (YB1 or YBX1) in treatments for conditions including gynecological, breast, bladder, kidney, head and neck, neuronal, and prostate cancers, lymphomas, and leukemias. Methods of their use in sensitizing resistant cancers to treatment with anticancer agents and radiation are also provided.
Type:
Application
Filed:
December 3, 2021
Publication date:
January 18, 2024
Applicants:
Oregon Health & Science University, The Board of Trustees of the Leland Stanford Junior University
Inventors:
Sanjay V. Malhotra, Dhanir Tailor, Arpit Dheeraj
Abstract: Disclosed is a handheld laser probe for laser thermal conjunctivoplasty, the handheld laser comprising: a forceps; and a line focused laser light source coupled to the forceps, wherein the forceps are configured to grasp a conjunctival fold and hold the fold in a light beam of the line focused laser, and wherein the line focused laser beam is configured to uniformly heat the conjunctival fold held in the forceps. Disclosed are systems for laser thermal conjunctivoplasty including the handheld laser. Disclosed are methods of conjunctivoplasty using the handheld laser probe.
Type:
Application
Filed:
September 26, 2023
Publication date:
January 11, 2024
Applicant:
Oregon Health & Science University
Inventors:
David Huang, Gangjun Liu, Jianlong Yang, Stephen Pflugfelder
Abstract: Disclosed are adeno-associated viral vectors and plasmids encoding the same. Also disclosed are methods of using adeno-associated viral vectors to deliver a protein of interest to the subject. The disclosed vectors have phenotypes including but not limited to increased retention in the blood of a subject, avoidance of the liver, and transduction of the brain and other tissues.